Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 43598-751
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 43598-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bupropion-label1 (Bupropion Label1)
This is a medication description for NDC 43598-751-60, which is an extended-release tablet of buPROPion HCI taken twice a day. It is important to avoid combining this medication with ZYBAN or any other medication that contains bupropon hydrochioride. This medication should only be dispensed with the accompanying ModificationGeid 1o sch pair warning. The medication is available in a bottle containing 60 tablets and is exclusively for prescription. However, there are some unreadable characters towards the end of the text.*
Bupropion-label2 (Bupropion Label2)
Bupropion-label3 (Bupropion Label3)
Bupropion-label4 (Bupropion Label4)
Product description: NDC 43598-752-60. This is a medication for oral use, sold in a bottle containing 60 extended-release tablets of buPROPion HCI. It is recommended to take it twice a day after initial titration. It is important to note that it should not be used with ZYBANS or any other medication containing bupropion hydrochloride. This medication should be kept at a temperature between 20°C to 25°C and it requires a prescription to purchase.*
Bupropion-label5 (Bupropion Label5)
Bupropion-label6 (Bupropion Label6)
This is a prescription drug information label for a medication called Twice-Day (fer Il Tiraion) with the active ingredient buPROPion HCI, in extended-release tablets of 150mg. The label warns against taking the medication along with any other medicine that contains bupropion hydrochloride. The package contains 500 tablets and it is distributed by Dr. Reddy's Laboratories Ltd.*
Bupropion-label7 (Bupropion Label7)
This is a description of a medication called Twice-A-Day (After Initial Titration) which contains BuPROPion HCI. It is an extended-release tablet that contains 200mg of the active ingredient. This medication should not be combined with Zyban or any medication that contains bupropion. The package contains 60 tablets made by Dr. Reddy's Pharmaceuticals. There is a warning against improper combinations with other drugs that contain bupropion.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.